ArticleThe Journal of biological chemistry2026
Kindlin-3 sustains cytokine interleukin-2 signaling by linking its receptor to integrin LFA-1.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Integrin Activation: Kindlin-3 as an Organiser of Immune Receptor Signalling.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kindlins are adaptor proteins that function synergistically with talin to activate integrins, facilitating cell adhesion and migration. In addition to this role, kindlins have other functions. In immune cells, kindlin-3 is the predominant kindlin paralog. Loss of kindlin-3 due to gene mutations leads to a bleeding disorder and impaired immune function, as observed in patients with leukocyte adhesion deficiency type III (LAD-III). In this study, we demonstrate that kindlin-3 maintains IL-2Rβ at the plasma membrane, a process that relies on the integrin LFA-1. This retention supports IL-2 signaling and helps protect natural killer (NK) cells from apoptosis when IL-2 levels are low. Kindlin-3 also promotes the colocalization of integrin LFA-1 and IL-2Rβ at sites where LFA-1 engages its ligand. Mechanistically, kindlin-3 directly binds the cytoplasmic domain of the interleukin-2 receptor β chain (IL-2Rβ) via its F0 subdomain. This interaction specifically targets a membrane-distal region of IL-2Rβ (residues 530-551) with micromolar affinity. Therefore, kindlin-3 acts as a bridging molecule that connects IL-2Rβ to the integrin LFA-1, thereby potentially coordinating cell adhesion with cytokine signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.